Global cancer profiling market expected to grow $54.8 billion by 2018

NewsGuard 100/100 Score

Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.

The global market for cancer profiling technologies reached $26.1 billion in 2012. This market is expected to grow to nearly $30.1 billion in 2013 and $54.8 billion in 2018, a compound annual growth rate (CAGR) of 12.8% over the five-year period, 2013 to 2018.

This report provides:

  • An overview of the global market for cancer profiling and biomarker studies
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Discussion of products in this market, cancer markets in newly emerging tools, diagnostics and therapeutics, and their impacts on the market
  • Examination of evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering the molecular mechanisms involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers
  • Identifications of important cancer profiling techniques, market share by type of products on the market and market share by company, as well as types of cancers and biomarkers
  • Coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials, and currently marketed and clinical-stage development products
  • Comprehensive company profiles of key players in the market.

Table of Contents

CHAPTER 1 INTRODUCTION
CHAPTER 2 SUMMARY
CHAPTER 3 OVERVIEW
CHAPTER 4 CURRENT PROFILING TECHNIQUES
CHAPTER 5 EPIGENOMIC PROFILING
CHAPTER 6 PROTEOMICS
CHAPTER 7 GLYCOMICS
CHAPTER 8 METABOLOMICS
CHAPTER 9 BIOINFORMATICS, DATABASES AND PATHWAY ANALYSIS
CHAPTER 10 CANCER PROFILING AND CLINICAL DEVELOPMENT
CHAPTER 11 MARKET
CHAPTER 12 COMPANY PROFILES
CHAPTER 13 CANCER PROFILING: PATENT LANDSCAPE AND LATEST DEVELOPMENTS
CHAPTER 14 REFERENCES
CHAPTER 15 CITED REFERNCES
LIST OF TABLES

Source:

Global Information, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers